PRMT5 is a Poor Prognostic Marker for NSCLC and Inhibition of PRMT5 Results in Increased Lung Cancer Sensitivity to Cisplatin and Radiotherapy

被引:0
|
作者
Welliver, Meng [1 ]
Jin, Feng [2 ]
Otterson, Gregory [1 ]
Carbone, David [3 ]
机构
[1] Ohio State Univ Ccc, Radiat Oncol, Columbus, OH USA
[2] Ohio State Univ, Radiat Oncol, Columbus, OH 43210 USA
[3] Ohio State Univ Ccc, Internal Med, Columbus, OH USA
关键词
D O I
10.1016/j.jtho.2016.11.1144
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.01-092
引用
收藏
页码:S844 / S844
页数:1
相关论文
共 50 条
  • [1] Inhibition of PRMT5 results in radiosensitization in lung cancer cell lines
    Sharma, Smitha
    Wu, X.
    Smith, P.
    Denko, N.
    Li, C.
    Lai, H.
    Yan, F.
    Shilo, K.
    Chakravarti, A.
    Sif, S.
    Baiocchi, R.
    Otterson, G.
    Xu-Welliver, Meng
    CANCER RESEARCH, 2014, 74 (19)
  • [2] PRMT5 function and targeting in cancer
    Kim, Hyungsoo
    Ronai, Ze'ev A.
    CELL STRESS, 2020, 4 (08) : 199 - 215
  • [3] Role of PRMT1 and PRMT5 in Breast Cancer
    Martinez, Sebastien
    Sentis, Stephanie
    Poulard, Coralie
    Tredan, Olivier
    Le Romancer, Muriel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [4] Antitumor Effects of PRMT5 Inhibition in Sarcomas
    Verbeke, Stephanie
    Bourdon, Aurelien
    Guegan, Jean-Philippe
    Leroy, Laura
    Chaire, Vanessa
    Richard, Elodie
    Bessede, Alban
    Italiano, Antoine
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (11): : 2211 - 2220
  • [5] PRMT1 loss sensitizes cells to PRMT5 inhibition
    Gao, Guozhen
    Zhang, Liang
    Villarreal, Oscar D.
    He, Wei
    Su, Dan
    Bedford, Ella
    Moh, Phoebe
    Shen, Jianjun
    Shi, Xiaobing
    Bedford, Mark T.
    Xu, Han
    NUCLEIC ACIDS RESEARCH, 2019, 47 (10) : 5038 - 5048
  • [6] Autophagy dictates sensitivity to PRMT5 inhibitor in breast cancer
    Brobbey, Charles
    Yin, Shasha
    Liu, Liu
    Ball, Lauren E.
    Howe, Philip H.
    Delaney, Joe R.
    Gan, Wenjian
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [7] Autophagy dictates sensitivity to PRMT5 inhibitor in breast cancer
    Charles Brobbey
    Shasha Yin
    Liu Liu
    Lauren E. Ball
    Philip H. Howe
    Joe R. Delaney
    Wenjian Gan
    Scientific Reports, 13
  • [8] Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer
    Hartley, Antja-Voy
    Wang, Benlian
    Jiang, Guanglong
    Wei, Han
    Sun, Mengyao
    Prabhu, Lakshmi
    Martin, Matthew
    Safa, Ahmad
    Sun, Steven
    Liu, Yunlong
    Lu, Tao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [9] PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells
    Bajbouj, Khuloud
    Ramakrishnan, Rakhee K.
    Saber-Ayad, Maha
    Omar, Hany A.
    Saheb Sharif-Askari, Narjes
    Shafarin, Jasmin
    Elmoselhi, Adel B.
    Ihmaid, Ahmed
    AlHaj Ali, Suhib
    Alalool, Abdulla
    Abdullah, Reem
    Hamid, Qutayba
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [10] Characterization of factors affecting sensitivity and resistance to PRMT5 inhibition in glioblastoma
    Tsai, Tsung-Lin
    CANCER RESEARCH, 2022, 82 (12)